Crude and adjusted ORs with associated 95% CIs of BMI categories for cancer stratified by NAFLD in 233 patients with T2DM
| Variables | Crude OR | Adjusted OR† | ||||
| OR | 95% CI | P value | OR | 95% CI | P value | |
| Non-NAFLD | ||||||
| BMI category (kg/m2) | ||||||
| Underweight or normal weight (<23.0) | 1.000 | 1.000 | ||||
| Overweight (23.0–24.9) | 1.212 | 0.105 to 13.949 | 0.878 | 4.868 | 0.121 to 196.076 | 0.401 |
| Obesity (≥25.0) | 1.750 | 0.282 to 10.863 | 0.548 | 2.943 | 0.228 to 38.023 | 0.408 |
| Trend test | 0.545 | 0.476 | ||||
| NAFLD | ||||||
| BMI category (kg/m2) | ||||||
| Underweight or normal weight (<23.0) | 1.000 | 1.000 | ||||
| Overweight (23.0–24.9) | 0.667 | 0.126 to 3.526 | 0.633 | 1.919 | 0.174 to 21.223 | 0.595 |
| Obesity (≥25.0) | 0.170 | 0.030 to 0.952 | 0.044* | 0.244 | 0.025 to 2.390 | 0.226 |
| Trend test | 0.021* | 0.060 | ||||
*P<0.05.
†Adjusted for sex, age, ever smoking, ever drinking, systolic and diastolic blood pressure, triglyceride, total cholesterol, HDL-cholesterol and LDL-cholesterol, HbA1c, serum uric acid, oral hypoglycemic medications and insulin use.
BMI, body mass index; HbA1c, glycosylated hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NAFLD, non-alcoholic fatty liver disease.